Neue Forschung zum Thema gefälschte Medikamente

Die amerikanischen National Institutes of Health haben eine Pressemitteilung veröffentlicht, in der sie auf Artikel hinweisen, die gerade vom The American Journal of Tropical Medicine and Hygiene veröffenlicht wurden. (Dieser Link führt zu den Abstracts und dieser Link zum Vorwort.) In den 17 Beiträgen geht es um neue Studien sowie um Vorschläge, was man tun sollte, um das Problem in den Griff zu bekommen.

Der Titel eines Artikels spricht sehr treffend von „Murder by Medicine“ und genau das ist es in vielen Fällen, allerdings nicht durch echte Medizin, sondern durch minderwertige Nachahmungen.

Hier ein Auszug aus der Pressemitteilung:

Global pandemic of fake medicines poses urgent risk, scientists say

Poor quality medicines are a real and urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis, according to the editors of a collection of journal articles published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Among the collection is an article describing the discovery of falsified and substandard malaria drugs that caused an estimated 122,350 deaths in African children in 2013.

Seventeen articles in all, detailing various aspects of the issue and proposing possible solutions, are included in a special journal supplement “The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives,” published online ahead of print by The American Journal of Tropical Medicine and Hygiene. Several articles suggest policy interventions, including an international framework and the adoption of stricter national laws against drug counterfeiting.

In an introductory essay, former U.S. Food and Drug Administration Commissioner Margaret Hamburg, M.D., says globalization has added layers of complexity to the drug supply chain that require greater oversight. “Today’s medical-product landscape blurs the line between domestic and foreign production, drawing attention to the need for global quality and safety oversight to prevent patient exposure to falsified products,” wrote Dr. Hamburg, who was recently named foreign secretary of the Institute of Medicine.

Scientists inspected the quality of about 16,800 samples of anti-malarials, anti-tuberculosis medicines, antibiotics and anti-leishmaniasis drugs and reported from 9 to 41 percent failed to meet the specifications. Seven separate studies were carried out, primarily in low-resource settings, and included samples from public and private sources.

Die Fettungen in dem Text stammen von mir.

Dieser Post ist wie alle zu diesem Thema auch ein Service für die Leser meines Buches Tödliche Imitate, die hier im Blog kontinuierlich neue ergänzende Informationen zum Thema gefälschte Medikamente finden.

TODLICHE IMITATE - 2000